13D Watch Daily Intelligence Brief

This Amendment amends and supplements Item 4 of the Original Schedule 13D by adding the following: Confirmatory Letter On August 6, 2026, the Consortium jointly submitted a confirmatory letter (the "Confirmatory Letter") to the Board to reaffirm the Cash Consideration of $7.02 per share set out in the Revised Proposal submitted by the Consortium on July 27, 2026, as its best and final non-binding offer and to confirm that the Consortium's due diligence exercise has been completed. The Confirmatory Letter further reaffirms that the Consortium is interested only in acquiring the Shares (on a fully diluted basis), and the Consortium does not intend to sell their Shares to any third party in any alternative takeover transaction. All other terms of the Revised Proposal and proposal made by the Consortium on May 28, 2026, including the Rollover, remain unchanged. The Confirmatory Letter is non-binding, and no agreement, arrangement or understanding between the Consortium, on the one hand, and the Issuer, on the other hand, relating to the Confirmatory Letter, the Proposed Transaction or any other transaction will be created until such time as definitive agreements for the Proposed Transa…

This Amendment amends and supplements Item 4 of the Original Schedule 13D by adding the following: Confirmatory Letter On August 6, 2026, the Consortium jointly submitted a confirmatory letter (the "Confirmatory Letter") to the Board to reaffirm the Cash Consideration of $7.02 per share set out in the Revised Proposal submitted by the Consortium on July 27, 2026, as its best and final non-binding offer and to confirm that the Consortium's due diligence exercise has been completed. The Confirmatory Letter further reaffirms that the Consortium is interested only in acquiring the Shares (on a fully diluted basis), and the Consortium does not intend to sell their Shares to any third party in any alternative takeover transaction. All other terms of the Revised Proposal and proposal made by the Consortium on May 28, 2026, including the Rollover, remain unchanged. The Confirmatory Letter is non-binding, and no agreement, arrangement or understanding between the Consortium, on the one hand, and the Issuer, on the other hand, relating to the Confirmatory Letter, the Proposed Transaction or any other transaction will be created until such time as definitive agreements for the Proposed Transa…

The Board of Directors (the "Board") is reporting beneficial ownership of 102,098,469 shares of Common Stock (the "Shares") held by the MetLife Policyholder Trust (the "Trust") under the Plan of Reorganization, dated September 28, 1999, as amended (the "Plan"), of Metropolitan Life Insurance Company ("MetLife"). On April 7, 2000, 494,466,664 Shares were issued to the Trust pursuant to Section 5.2(d) of the Plan, a copy of which is attached as an exhibit to this statement. No consideration has been separately provided therefor by any member of the Board, except for Shares allocated to such member pursuant to the Plan. Since April 7, 2000, transactions by Beneficiaries (i) under the Purchase and Sale Program provided for by the Trust Agreement (as defined below), (ii) pursuant to the Issuer's split-off of Reinsurance Group of America, Incorporated, in September 2008, and (iii) to withdraw Shares from the Trust, as well as escheatment of unclaimed Shares, have resulted in a decrease in the number of Shares held by the Trust from 494,466,664 to 102,098,469 (as adjusted to reflect refinements in the calculation of the number of Shares issued to the Trust under the Plan). Under the Plan …